Our team has a dream: to reinvent the way we observe and treat the human brain. Neuroelectrics has created diagnostic and treatment telemedicine wireless platforms based on Starstim and Enobio, combining multichannel transcranial current stimulation such as tDCS with EEG. We aim to help patients recover their brain health in pathologies such as chronic pain and stroke rehabilitation. You can find us in our offices in Boston (MA-US) and Barcelona (Spain).
Ana Maiques is the CEO of Neuroelectrics, a company aiming to change the way we interact with the brain, developing innovative technologies to monitor and stimulate the brain to help many patients in need. She was nominated by IESE as one of the most influential entrepreneurs under 40 in Spain (2010) and received the EU Prize for Women Innovators from the European Commission EC in 2014 and one of the Most Inspiring Fifty Women in Europe. Neuroelectrics recently received the Best Start-up in Health 2015 bye Wired UK magazine in an amazing event in London. She spends her time between Barcelona and Boston.
Dr. Giulio Ruffini obtained a BA in math and physics from Berkeley and a PhD in theoretical physics from UC Davis/LANL in 1995. In 2000 he and others founded Starlab to transform science into technologies with impact. He has provided the science and technology visions for Neuroelectrics, and believes that neuromodulation will make great advances thanks to the union of precision multifocal stimulation technologies with advanced biophysical and neuro-computational models, EEG and fMRI. His recent paper on brain-to-brain communication was the 9th most shared paper of 2014.
Uri coursed Business Management in Israel (The College of Management) and an MBA at IESE Business School. He has worked intensively in Israel, Switzerland, USA, Holland and Spain, having acquired great experience in the medical sector. Just after graduating, he launched a start-up in the cardiovascular field in his homeland: Israel. Before joining Neuroelectrics, Uri worked at Medtronic, Inc. There, he held several sales and marketing leadership roles in Europe and Latin America. His roles included product management for the coronary stent marketing group, which achieved over $200 million in annual sales. In his last role in Medtronic Uri held a sales management position managing the Cardiovascular business in Eastern Europe and Central Asia holding P&L reasonability for a $20 million annual sales.
Paul graduated with a BS in Electrical Engineering from Carnegie-Mellon University in Pittsburgh PA, and an MBA from the Institute for Management Development (IMD) in Lausanne, Switzerland. Paul has been a founder and executive in several life sciences start-up companies, including Aleva Neurotherapeutics, a spin-off from the Swiss Federal Institute of Technology of Lausanne (EPFL) developing advanced deep-brain stimulation systems for treatment of Parkinson’s disease and other movement disorders, and NetBio (Waltham, MA), a spin-off from the Whitehead Institute at MIT developing rapid DNA analysis systems for defense, security, and infectious disease diagnostics. Prior to this, Paul was an executive officer with the electronics technology company Ansoft Corporation (NASDAQ:ANST, acquired by ANSYS) where, among other roles, he set-up and managed all Japanese and Asian operations.
Born in Spain in 1961, MD and PhD degrees in Neurophysiology from the Albert Ludwigs University in Germany. He also trained at he University of Minnesota and the US National Institutes of Health. Currently he is the Principal Investigator of the Center for Non-Invasive Brain Stimulation and Professor of Neurology at Harvard Medical School and the Beth Israel Deaconess Medical Center (Boston, USA). He is a world leader in the development of brain stimulation technologies (TMS and tDCS).
Dr. Adam Gazzaley obtained an M.D. and a Ph.D. in Neuroscience at the Mount Sinai School of Medicine in New York, completed clinical residency in Neurology at the University of Pennsylvania, and postdoctoral training in cognitive neuroscience at UC Berkeley. He is the founding director of the Neuroscience Imaging Center at the UC San Francisco, an Associate Professor in Neurology, Physiology and Psychiatry, and Principal Investigator of a cognitive neuroscience laboratory.
Wellcome RCD Fellow and University Research Lecturer at the University of Oxford, Prof. Kadosh is a leader in the study of the neuropsychological mechanisms of numerical and magnitude processing using advanced techniques such as tCS/tES. His main research focuses on the psychological and biological factors that shape learning and cognitive achievements. Understanding and enhancing learning and cognition have significant implications to different fields including psychology, neuroscience, education, and medicine, and have a translational impact for cognitive enhancement for clinical and non-clinical populations.
Currently, he is a Professor for Clinical Neurophysiology in the University of Göttingen (Germany). He is a tDCS pioneer and a key opinion leader in the field of non-invasive brain stimulation, neuroplasticity and neuropsychopharmacology, among others.
Niels Birbaumer is one of the leading figures in the history of brain-computer interfaces (BCI), which are direct communication devices between the brain and a computer. Birbaumer has been dealing with BCIs for as much as forty years. He believes in the power of BCIs, a power that is based on human imagination and is used to treat brain disturbances. The director of the Institute of Medical Psychology and Behavioural Neurology in Tübingen was awarded the prestigious Leibniz Prize in 1995 for his pioneering work on BCIs.
Neurokai - a Starlab division - is our partner for advanced data analysis services. Neurokai provides services in all aspects of neuromonitoring and neuromodulation of the electrical brain using EEG and tCS technologies. They are experts in EEG data analysis, applying advanced signal processing, statistical methods and machine learning techniques to real world data sets. Their services range from protocol definition to data collection, data cleaning, artefact removal and validation. They structure they offering in three blocks: Experience - Performance - Biomarkers.
Starlab Neuroscience is our R&D partner, including development of advanced products and data processing. Starlab Neuroscience Research aims to be a world leader in applied neuroscience. Through fundamental and applied research, they explore new technologies and techniques with the potential for real world impact as products and services. Their technology products are being commercialized through Neuroelectrics while their analysis services are being offered under the brand Neurokai.
Pedro Cavaleiro Miranda obtained a BSc and a PhD in Physics from the University of Sussex, UK and an MSc in Computer Science from UCL, UK. He is currently an Associate Professor in the Faculty of Science of the University of Lisbon, where he teaches Biomedical Engineering, and a researcher at the Institute of Biophysics and Biomedical Engineering, in the same University. His expertise lies in the calculation of the electric field induced by non-invasive brain stimulation techniques, based on realistic models of the human head.
Pre- and post-doctoral applications are invited for an experienced and enthusiastic Biomedical Engineer/Physicist to work on the project “Transcranial brain stimulation as innovative therapy for chronic pediatric neuropsychiatric disorders” — STIPED, funded by the European Union’s Horizon 2020 research and innovation programme under grant agreement No 731827. The location for this research will mainly be the workgroup of Prof. Pedro Miranda at the University of Lisbon, Portugal. Expected close collaborations and visits are to the partnering Neuroelectrics...See more
Chronic mental health disorders, such as attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD), are common diagnoses in children and adolescents. The traditional treatment of these diseases envisages the use of drugs and psychotherapy. An international consortium, under the leadership of Professor Michael Siniatchkin of the Faculty of Medicine at Kiel University (CAU), is investigating an alternative treatment method, in which the brain is stimulated with low amplitude direct current. The scientists and researchers also want to develop a device that enables treatment...See more